FindTrial
Sign In

Telemedicine-Assisted Structured Self-Monitoring of Blood Glucose in Management of T2DM Results of a randomized clinical trial

Clinical application research of diabetes mobile medical management based on cloud service platform in Qingpu District

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072356
Enrollment
Unknown
Registered
2023-06-12
Start date
2016-06-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Self monitoring group for remote medical support:Patients in the test group received a blood glucose meter(BGM). The name of the BGM was SINOMEDISITE which connected to the APP(Huayi Glucose Butler) t
Regular self-monitoring group:Patients in the control group received a blood glucose meter(BGM). The name of the BGM was SINOMEDISITE which not connected to the APP (Huayi Glucose Butler). The subjec

Sponsors

Qingpu Branch of Zhongshan Hospital affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: T2DM with suboptimal glycemic control (7% < HbA1c < 8%), aged 18–75 years, with a diabetes duration of 5–10 years and unified signing of informed consent form

Exclusion criteria

Exclusion criteria: The exclusion criteria were acute infection, malignant tumor, liver failure, pregnancy or lactation, long-term cortisol treatment, and inability to use smartphone applications

Design outcomes

Primary

MeasureTime frame
Glycosylated hemoglobin;fasting blood glucose;readings in range;—

Secondary

MeasureTime frame
LBGI;DSMQ;—

Countries

China

Contacts

Public ContactMin Zhang

Qingpu Branch of Zhongshan Hospital affiliated to Fudan University

mynarrowgate@126.com+86 181 1601 6187

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026